As Americans grow increasingly frustrated with their healthcare system, a proposal that has long been kicked around on the Democratic periphery is showing up in debates and on political platforms: “Medicare for All.” According to a 2025 Economist-YouGov poll, nearly 60% of Americans favor a system of Medicare for All, while 85% of Democrats support…
That is the title of my most recent paper published in Clinical Lung Cancer with co-authors Mark Danese, Melissa Laurie, Beata Korytowsky, Shane Jordan, Debbie Ryan and Sukhmani K. Padda. The study abstract is below. ObjectiveThis study examined brain metastases among patients with metastatic non-small cell lung cancer (mNSCLC), characterizing prevalence, use of brain imaging,…
I spent some time figuring out and getting a little help in uploading my health records to Claude, using HealthEx. I did the demo with Ruheed Mohamed, the head of technical services, and then I interviewed CEO Priyanka Agarwal, MD. This shows how Healthex gets data and incorporates it into Claude, and where Priyanka thinks…
Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder. The post Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder appeared first on MedCity News.
HAVANA, Florida. — Para ser una comunidad rural, este pueblo de 1,750 habitantes ha sido más afortunado que la mayoría. Aquí ha ejercido un médico de familia durante los últimos 30 años. Pero eso se acabó en diciembre cuando Mark Newberry se jubiló. Para atraer a un nuevo médico, los líderes de Havana publicaron anuncios…
By CHINELO GRACE CHIGOZIE The U.S. has a healthcare cost problem that everyone knows about but no one talks about openly. For decades, the same medical treatment has cost very different amounts. Hospitals down the street from each other might charge five times more or less for the exact same thing. Patients couldn’t find out…
Joining Matthew Holt (@boltyboy) on #THCBGang on Friday November 8 are THCB regular writer and ponderer of odd juxtapositions Kim Bellard (@kimbbellard); Principal of Worksite Health Advisors Brian Klepper (@bklepper1); patient safety expert and all around wit Michael Millenson (@mlmillenson); and digital health investment banker Steven Wardell (@StevenWardell). There may well be a discussion about an election….
This KFF analysis uses 2023 T-MSIS Research Identifiable Files to look at where reproductive-age female Medicaid enrollees received their last contraceptive visit by state. Overall, more than four in 10 (43%) female Medicaid enrollees received their last contraceptive visit of 2023 at a safety net provider, which includes Planned Parenthood clinics, community health centers, state…
Health and Human Services Secretary Robert F. Kennedy Jr.’s testimony before the Senate Finance Committee follows the ouster last week of the director of the Centers for Disease Control and Prevention, Susan Monarez. At least four other senior CDC officials resigned in protest. What are the biggest takeaways? What comes next? Tune in for a…
Rebranding signifies a shift towards continuous intelligence before, during, and after procedures to support clinical workflows